Potential biomarkers of muscle injury after eccentric exercise

Biomarkers

Volumn 15, Issue 3, 2010, Pages 249-258

  Sietsema, Kathy E ^a   Meng, Fanyu ^b   Yates, Nathan A ^b   Hendrickson, Ronald C ^b   Liaw, Andy ^b   Song, Qinghua ^b   Brass, Eric P ^a   Ulrich, Roger G ^c,d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ROSETTA INPHARMATICS   (United States)

^d Calistoga Pharmaceuticals   (United States)

Author keywords

; 1 antichymotrypsin; C 1 protease inhibitor; Exercise; Proteomics

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 ANTICHYMOTRYPSIN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C1S INHIBITOR; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; LACTATE DEHYDROGENASE; MYOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; ECCENTRIC MUSCLE CONTRACTION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MUSCLE INJURY; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; VISUAL ANALOG SCALE;

ADULT; AGED; ALPHA 1-ANTICHYMOTRYPSIN; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; COMPLEMENT C1 INHIBITOR PROTEIN; CREATINE KINASE; EXERCISE; FEMALE; HEMOGLOBINS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MUSCLES; PEPTIDES; PROTEOMICS;

EID: 77951674377     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903502802     Document Type: Article

References (38)

1. Akaaboune M, Verdiere-Sahuque M, Lachkar S, Festof BW, Hantai D. (1995). Serine proteinase inhibitors in human skeletal muscle: expression of beta-amyloid protein precursor and alpha 1-antichymotrypsin in vivo and during myogenesis in vitro. J Cell Physiol 165:503-511
2. Alexandridis G, Pappas GA, Elisaf MS. (2000). Rhabdomyolysis due to combination therapy with cerivastatin and gemfbrozil. Am J Med 109:261-262
3. Anderson NL, Anderson NG. (2002). Te human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867
4. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B. (2007). Infammatory monocytes recruited after skeletal muscle injury switch into antiinfam-matory macrophages to support myogenesis. J Exp Med 204:1057-1069
5. Bannwarth B. (2002). Drug-induced myopathies. Expert Opin Drug Saf 1:65-70.
6. Businaro R, Nori SL, Toesca A, Evangelisti E, De Renzis G, Fumagalli L. (2001). Altered balance of proteinase inhibitors in atrophic muscle after denervation. Ital J Anat Embryol 106:159-165
7. Chen YW, Hubal MJ, Hofman EP, Tompson PD, Clarkson PM. (2003). Molecular responses of human muscle to eccentric exercise. J Appl Physiol 95:2485-2494
8. Clarkson PM, Kearns AK, Rouzier P, Rubin R, Tompson PD. (2006). Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc 38:623-627
9. Cnaan A, Laird NM, Slasor P. (1997). Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med 16:2349-2380
10. Coon JJ, Ueberheide B, Syka JE, Dryhurst DD, Ausio J, Shabanowitz J, Hunt DF. (2005). Protein identifcation using sequential ion/ion reactions and tandem mass spectrometry. Proc Natl Acad Sci USA 102:9463-9468
11. Eng J, McCormack A, Yates J. (1994). An approach to correlate tandem mass-spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5:976-989
12. Friden J, Lieber RL. (2001). Eccentric exercise-induced injuries to contractile and cytoskeletal muscle fbre components. Acta Physiol Scand 171:321-326
13. Friis H, Gomo E, Nyazema N, Ndhlovu P, Kaestel P, Krarup H, Michaelsen K F. (2002). HIV-1 viral load and elevated serum alpha(1)-antichymotrypsin are independent predictors of body composition in pregnant Zimbabwean women. J Nutr 132:3747-3753
14. Guis S, Mattei JP, Liote F. (2003). Drug-induced and toxic myopa-thies. Best Pract Res Clin Rheumatol 17:877-907.
15. Hack CJ. (2004). Integrated transcriptome and proteome data: the challenges ahead. Brief Funct Genomic Proteomic 3:212-219
16. Hirose L, Nosaka K, Newton M, Laveder A, Kano M, Peake J, Suzuki K. (2004). Changes in infammatory mediators following eccentric exercise of the elbow fexors. Exerc Immunol Rev 10:75-90.
17. Jackson CE. (2008). A clinical approach to muscle diseases. Semin Neurol 28:228-240
18. Lavender AP, Nosaka K. (2006). Responses of old men to repeated bouts of eccentric exercise of the elbow fexors in comparison with young men. Eur J Appl Physiol 97:619-626
19. Lieber RL, Shah S, Friden J. (2002). Cytoskeletal disruption after eccentric contraction-induced muscle injury. Clin Orthop Relat Res (Suppl.):S90-9.
20. Mann M, Hendrickson RC, Pandey A. (2001). Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 70:437-473
21. Meng F, Wiener MC, Sachs JR, Burns C, Verma P, Paweletz CP, Mazur MT, Deyanova EG, Yates NA, Hendrickson RC. (2007). Quantitative analysis of complex peptide mixtures using FTMS and diferential mass spectrometry. J Am Soc Mass Spectrom 18:226-233
22. Murohara T, Guo JP, Lefer AM. (1995). Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury. J Pharmacol Exp Ther 274: 1246-1253
23. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. (2005). Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 41:380-382
24. Nicholson GA, McLeod JG, Morgan G, Meerkin M, Cowan J, Bretag A, Graham D, Hill G, Robertson E, Shefeld L. (1985). Variable distributions of serum creatine kinase reference values. Relationship to exercise activity. J Neurol Sci 71:233-245
25. Nosaka K, Clarkson PM. (1996). Variability in serum creatine kinase response after eccentric exercise of the elbow fexors. Int J Sports Med 17:120-127
26. Nosaka K, Newton M, Sacco P. (2002). Delayed-onset muscle soreness does not refect the magnitude of eccentric exercise-induced muscle damage. Scand J Med Sci Sports 12:337-346
27. Peake J, Nosaka K, Suzuki K. (2005). Characterization of infamma-tory responses to eccentric exercise in humans. Exerc Immunol Rev 11:64-85.
28. Pieper R, Su Q, Gatlin CL, Huang ST, Anderson NL, Steiner S. (2003). Multi-component immunoafnity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3:422-432
29. Ricaurte B, Guirguis A, Taylor HC, Zabriskie D. (2006). Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity. Ann Pharmacother 40: 753-757
30. Schaap LA, Pluijm SM, Deeg DJ, Visser M. (2006). Infammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119:526.e9-17
31. Seachrist JL, Loi CM, Evans MG, Criswell KA, Rothwell CE. (2005). Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity. Toxicol Sci 88:551-561
32. Semple SJ, Smith LL, McKune AJ, Hoyos J, Mokgethwa B, San Juan AF, Lucia A, Wadee AA. (2006). Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espana. Br J Sports Med 40:124-127
33. Smith JA. (1995). Exercise, training and red blood cell turnover. Sports Med 19:9-31.
34. Sorichter S, Puschendorf B, Mair J. (1999). Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fber injury. Exerc Immunol Rev 5:5-21.
35. Urso ML, Clarkson PM, Hittel D, Hofman EP, Tompson PD. (2005). Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins. Arterioscler Tromb Vasc Biol 25:2560-2566
36. Veenstra J, Smit WM, Krediet RT, Arisz L. (1994). Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant 9:637-641
37. Zhang H, Li XJ, Martin DB, Aebersold R. (2003). Identifcation and quantifcation of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 21:660-666
38. Zhang H, Yi EC, Li XJ, Mallick P, Kelly-Spratt KS, Masselon CD, Camp DG 2nd, Smith RD, Kemp CJ, Aebersold R. (2005). High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spec-trometry. Mol Cell Proteomics 4:144-155